Cara Therapeutics Inc (NASDAQ: CARA) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Matthew Murphy -- Manager of Investor Relations Christopher Posner -- Chief
Cara Therapeutics Inc (CARA) Q1 2023 Earnings Call Transcript
Categories
Health Care
TRxADE HEALTH Inc (MEDS) Q1 2023 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ: MEDS) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Prashant Patel -- Interim Chief Financial Officer Suren Ajjarapu -- Chairman and
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31%
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter of fiscal
Bio Path Holdings Inc (BPTH) Q1 2023 Earnings Call Transcript
Bio Path Holdings Inc (NASDAQ:BPTH) Q1 2023 Earnings Call dated May. 12, 2023. Corporate Participants: Will O'Connor -- Managing Director Peter H. Nielsen -- Chairman, President,
Catalyst Pharmaceuticals Inc (CPRX) Q1 2023 Earnings Call Transcript
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Q1 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer and Treasurer
Veru Inc (VERU) Q2 2023 Earnings Call Transcript
Veru Inc (NASDAQ:VERU) Q2 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Samuel Fisch -- Executive Director of Investor Relations and Corporate Communications
BioLife Solutions Inc (BLFS) Q1 2023 Earnings Call Transcript
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman & Chief
Jazz Pharmaceuticals PLC (JAZZ) Q1 2023 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Andrea Flynn -- Vice President and Head, Investor Relations Bruce
Perrigo Co PLC (PRGO) Q1 2023 Earnings Call Transcript
Perrigo Co PLC (NYSE: PRGO) Q1 2023 Earnings Call dated May. 09, 2023. Corporate Participants: Bradley Joseph -- Vice President of Investor
A snapshot of McKesson Corporation’s Q4 2023 earnings
Healthcare service provider McKesson Corporation (NYSE: MCK) announced financial results for the fourth quarter of 2023, reporting a 4% increase in revenues.
McKesson Corporation (MCK) Q4 2023 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q4 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Nicole Kramer -- Manager of Investor Relations Brian Tyler -- Chief Executive Officer
ANI Pharmaceuticals Inc (ANIP) Q1 2023 Earnings Call Transcript
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- Chief Executive Officer Stephen
GoHealth Inc (GOCO) Q1 2023 Earnings Call Transcript
GoHealth Inc (NASDAQ:GOCO) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: John Shave -- Vice President of Investor Relations Vijay Kotte -- Chief Executive
Ventas, Inc (VTR) Q1 2023 Earnings Call Transcript
Ventas, Inc (NYSE: VTR) Q1 2023 Earnings Call dated May. 09, 2023 Corporate Participants: BJ Grant — Senior Vice President-Investor Relations Debra A. Cafaro — Chairman
PetIQ, inc (PETQ) Q1 2023 Earnings Call Transcript
PetIQ, inc (NASDAQ: PETQ) Q1 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Katie Turner -- Investor Relations Cord Christensen --
Cigna Corporation (CI) Q1 2023 Earnings Call Transcript
Cigna Corporation (NYSE:CI) Q1 2023 Earnings Call dated May. 05, 2023. Corporate Participants: Ralph Giacobbe -- Senior Vice President & Head of Investor Relations
CI Earnings: Key quarterly highlights from Cigna’s Q1 2023 financial results
The Cigna Group (NYSE: CI) reported first quarter 2023 earnings results today. Total revenues increased 6% year-over-year to $46.5 billion. Adjusted revenues increased
MetLife Inc (MET) Q1 2023 Earnings Call Transcript
MetLife Inc (NYSE: MET) Q1 2023 Earnings Call dated May. 04 Corporate Participants: Michel Khalaf -- President and Chief Executive Officer John
Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite an increase
Zoetis Inc (ZTS) Q1 2023 Earnings Call Transcript
Zoetis Inc (NYSE:ZTS) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Steve Frank -- Vice President of Investor Relations Kristin
Ironwood Pharmaceuticals, Inc (IRWD) Q1 2023 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Matt Roache -- Director, Investor Relations Thomas McCourt